Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access

Am J Infect Control. 2014 Oct;42(10):1130-2. doi: 10.1016/j.ajic.2014.06.027.

Abstract

Sixty-four patients with chlorhexidine-silver sulfadiazine-impregnated catheters had a lower rate of catheter-related bloodstream infection and lower central venous catheter-related costs per catheter day than 190 patients with a standard catheter.

Keywords: Bacteremia; Central venous catheter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Catheter-Related Infections / prevention & control*
  • Catheterization / economics*
  • Catheterization / methods*
  • Central Venous Catheters / economics
  • Chlorhexidine / pharmacology*
  • Cost-Benefit Analysis
  • Disinfectants / pharmacology*
  • Female
  • Humans
  • Infection Control / economics
  • Infection Control / methods*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Silver Sulfadiazine / pharmacology*

Substances

  • Disinfectants
  • Chlorhexidine
  • Silver Sulfadiazine